Hydrochlorothiazide
- Product NDC
- 50090-0143
- 11-digit product format
- 500900143
- Labeler code
- 50090
- Product ID
- 50090-0143_bfca9229-46d2-41fc-8d24-1155a066cdd9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA040780
- Marketing category
- ANDA
- Marketing start
- 2007-07-20
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50090-0143-0 | 2021-06-14 | C162847 | 48780-1 | 9d75b9d1-1e27-f424-e053-dadaa90a57ce | 3a1e85d3-e4ea-4a46-a580-a5fe5e0135fd |
| 50090-0143-1 | 2021-06-14 | C162847 | 48780-1 | 9d75b9d1-1e27-f424-e053-dadaa90a57ce | 3a1e85d3-e4ea-4a46-a580-a5fe5e0135fd |
| 50090-0143-8 | 2021-06-14 | C162847 | 48780-1 | 9d75b9d1-1e27-f424-e053-dadaa90a57ce | 3a1e85d3-e4ea-4a46-a580-a5fe5e0135fd |
| 50090-0143-0 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-1e27-f424-e053-dadaa90a57ce | 3a1e85d3-e4ea-4a46-a580-a5fe5e0135fd |
| 50090-0143-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-1e27-f424-e053-dadaa90a57ce | 3a1e85d3-e4ea-4a46-a580-a5fe5e0135fd |
| 50090-0143-8 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-1e27-f424-e053-dadaa90a57ce | 3a1e85d3-e4ea-4a46-a580-a5fe5e0135fd |